After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
While the healthcare giant undoubtedly will be a force to reckon with in the years ahead, TeamHealth and Mednax may be in a position to benefit during the integration period.
If the U.S. dollar goes higher, one Jefferies analyst made the case for investing in small- and mid-cap stocks -- particularly ones that have little overseas sales exposure.
Apple, Microsoft and three others are not being rewarded for their success and frugality, Cramer says.
It's time to unload these toxic stocks from your portfolio.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.